Baird Medical Investment Holdings Limited(BDMD)

Medical - Devices · Guangzhou, GD

$0.74-0.01 (-1.09%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

Price/OCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/OCF ratio is N/A as of 2026-10-06T12:05:44.296Z.

Stored calculation inputs

Calculation as of: 2026-10-06T12:05:44.296Z.

Quote observation: 2026-10-05T20:00:02.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 31,356,890
TTM operating cash flow · period ending 2025-12-31: N/A

FMP input reference: 3c83d1468e5e3921618bd37e367f41e2e7287b0e28e44d51d30477b87a45d5ec

P/E Ratio|P/FCF Ratio|Operating Cash Flow|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

BDMD Price/OCF Ratio Metrics

PRICE/OCF RATIO

N/A

BDMD Competitors' Price/OCF Ratio

BDMD

Baird Medical Investment Holdings Limited

Current

Market Cap

$31.36M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNTX

Context Therapeutics Inc.

vs BDMD

Market Cap

$30.92M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CRVO

CervoMed Inc.

vs BDMD

Market Cap

$30.65M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EUDA

EUDA Health Holdings Limited

vs BDMD

Market Cap

$32.31M

Price/OCF Ratio

N/A

TTM Avg

503.18

3Y Avg

503.18

5Y Avg

503.18

BYSI

BeyondSpring Inc.

vs BDMD

Market Cap

$32.32M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALGS

Aligos Therapeutics, Inc.

vs BDMD

Market Cap

$33.42M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ATYR

aTyr Pharma, Inc.

vs BDMD

Market Cap

$28.43M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ARAY

Accuray Incorporated

vs BDMD

Market Cap

$35.89M

Price/OCF Ratio

N/A

TTM Avg

17.67

3Y Avg

45.36

5Y Avg

32.48

DCGO

DocGo Inc.

vs BDMD

Market Cap

$36.05M

Price/OCF Ratio

N/A

TTM Avg

2.00

3Y Avg

3.35

5Y Avg

33.77

BEAT

HeartBeam, Inc.

vs BDMD

Market Cap

$36.31M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/OCF RATIO	TTM	3Y	5Y
Baird Medical Investment Holdings Limited (BDMD)	$31.36M	N/A	N/A	N/A	N/A
Context Therapeutics Inc. (CNTX)vs ›	$30.92M	N/A	N/A	N/A	N/A
CervoMed Inc. (CRVO)vs ›	$30.65M	N/A	N/A	N/A	N/A
EUDA Health Holdings Limited (EUDA)vs ›	$32.31M	N/A	503.18	503.18	503.18
BeyondSpring Inc. (BYSI)vs ›	$32.32M	N/A	N/A	N/A	N/A
Aligos Therapeutics, Inc. (ALGS)vs ›	$33.42M	N/A	N/A	N/A	N/A
aTyr Pharma, Inc. (ATYR)vs ›	$28.43M	N/A	N/A	N/A	N/A
Accuray Incorporated (ARAY)vs ›	$35.89M	N/A	17.67	45.36	32.48
DocGo Inc. (DCGO)vs ›	$36.05M	N/A	2.00	3.35	33.77
HeartBeam, Inc. (BEAT)vs ›	$36.31M	N/A	N/A	N/A	N/A

Operating Cash Flow Valuation

P/OCF Ratio

N/A

P/FCF Ratio

N/A

Price/OCF Ratio Formula & Definition

P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Price/OCF Ratio: N/A

BDMD Price/OCF Ratio Metrics

BDMD Competitors' Price/OCF Ratio

Operating Cash Flow Valuation

Price/OCF Ratio Formula & Definition

Related Metrics